DK0606921T3 - Fremgangsmåde til isolering af Haemophilus influenzae protein E - Google Patents
Fremgangsmåde til isolering af Haemophilus influenzae protein EInfo
- Publication number
- DK0606921T3 DK0606921T3 DK94100492T DK94100492T DK0606921T3 DK 0606921 T3 DK0606921 T3 DK 0606921T3 DK 94100492 T DK94100492 T DK 94100492T DK 94100492 T DK94100492 T DK 94100492T DK 0606921 T3 DK0606921 T3 DK 0606921T3
- Authority
- DK
- Denmark
- Prior art keywords
- isolating
- extracting
- haemophilus influenzae
- protein
- influenzae protein
- Prior art date
Links
- 241000606768 Haemophilus influenzae Species 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 101710204837 Envelope small membrane protein Proteins 0.000 title 1
- 101710088839 Replication initiation protein Proteins 0.000 title 1
- 229940047650 haemophilus influenzae Drugs 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 239000007864 aqueous solution Substances 0.000 abstract 2
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32097189A | 1989-03-09 | 1989-03-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0606921T3 true DK0606921T3 (da) | 2000-09-04 |
Family
ID=23248627
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94100492T DK0606921T3 (da) | 1989-03-09 | 1990-03-09 | Fremgangsmåde til isolering af Haemophilus influenzae protein E |
DK90905112.0T DK0462210T3 (da) | 1989-03-09 | 1990-03-09 | Vacciner mod ikke-typebestemmelige Haemophilus influenzae |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90905112.0T DK0462210T3 (da) | 1989-03-09 | 1990-03-09 | Vacciner mod ikke-typebestemmelige Haemophilus influenzae |
Country Status (13)
Country | Link |
---|---|
US (4) | US5601831A (fr) |
EP (2) | EP0462210B1 (fr) |
JP (1) | JP2955014B2 (fr) |
KR (1) | KR100188323B1 (fr) |
AT (2) | ATE110965T1 (fr) |
AU (1) | AU648251B2 (fr) |
CA (1) | CA2047681C (fr) |
DE (2) | DE69033600T2 (fr) |
DK (2) | DK0606921T3 (fr) |
ES (2) | ES2063965T3 (fr) |
FI (1) | FI914241A0 (fr) |
NO (1) | NO913518L (fr) |
WO (1) | WO1990010458A1 (fr) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340888C (fr) * | 1988-09-01 | 2000-02-01 | Algis Anilionis | Vaccins et tests diagnostics pour haemophilus influezae |
US6797272B1 (en) | 1991-10-16 | 2004-09-28 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
US5422110A (en) * | 1991-10-16 | 1995-06-06 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
AU2699192A (en) * | 1991-10-16 | 1993-05-21 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
DE69423383T2 (de) * | 1993-05-13 | 2000-08-24 | American Cyanamid Co | Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken |
US5681570A (en) * | 1995-01-12 | 1997-10-28 | Connaught Laboratories Limited | Immunogenic conjugate molecules |
US20020032316A1 (en) * | 1995-03-31 | 2002-03-14 | Cantab Pharmaceuticals Research Limited | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
NZ306316A (en) * | 1995-04-17 | 2001-06-29 | Smithkline Beecham Biolog S | use of lipoprotein and a type 2T independent antigen to induce an immune response to the antigen |
AR003125A1 (es) * | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
GB9513074D0 (en) * | 1995-06-27 | 1995-08-30 | Cortecs Ltd | Novel anigen |
WO2002089839A1 (fr) * | 2001-05-03 | 2002-11-14 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunisation intranasale par un lipooligosaccharide detoxifie provenant d'un haemophilus influenzae ou d'un moraxella catarrhalis non typable |
US20040126381A1 (en) * | 1996-04-23 | 2004-07-01 | Xin-Xing Gu | Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella |
US6207157B1 (en) * | 1996-04-23 | 2001-03-27 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate vaccine for nontypeable Haemophilus influenzae |
ES2270537T3 (es) * | 1997-11-12 | 2007-04-01 | F. Hoffmann-La Roche Ag | Tratamiento de enfermedades inmunes mediadas por celulas t ayudantes de tipo 2. |
US6255050B1 (en) * | 1998-05-22 | 2001-07-03 | Lorne Park Research, Inc. | Dynamic hybridization system |
BR0011817B1 (pt) | 1999-06-25 | 2011-11-01 | processos para extrair proteìnas de membrana interna, para extrair proteìnas de membrana externa, para extrair proteìna p4 de membrana externa recombinante lipiadada (rp4), e, para extrair proteìna p6 de membrana externa recombinante lipidada (rp6). | |
US7101989B1 (en) | 1999-07-09 | 2006-09-05 | University Of North Carolina At Chapel Hill | DsrA protein and polynucleotides encoding the same |
US6391313B1 (en) * | 1999-07-15 | 2002-05-21 | Aventis Pasteur Limited | Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalis |
EP1210114A4 (fr) * | 1999-08-20 | 2004-01-02 | Gen Hospital Corp | Proteines de membrane externe a, lipoproteine associee a du peptidoglycane et lipoproteine de mureine comme cibles therapeutiques pour le traitement de la septicemie |
US7384640B1 (en) * | 1999-09-30 | 2008-06-10 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
US20030232055A1 (en) * | 2000-07-31 | 2003-12-18 | Ruslan Medzhitov | Innate immune system-directed vaccines |
WO2002009748A1 (fr) * | 2000-07-31 | 2002-02-07 | Yale University | Vaccins diriges vers le systeme immunitaire inne |
GB0025486D0 (en) * | 2000-10-17 | 2000-11-29 | Smithkline Beecham Biolog | Novel compounds |
US20030175287A1 (en) * | 2001-01-03 | 2003-09-18 | Yale University | Innate immune system-directed vaccines |
AT410798B (de) * | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
US6834384B2 (en) * | 2001-03-14 | 2004-12-21 | General Instrument Corporation | Methods and apparatus for upgrading firmware in an embedded system |
DE60234695D1 (de) | 2001-06-07 | 2010-01-21 | Univ Colorado | Mutantenformen von cholera holotoxin als adjuvans |
AU2002322380B2 (en) | 2001-06-07 | 2006-11-02 | Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences | Mutant forms of cholera holotoxin as an adjuvant |
WO2002100891A2 (fr) * | 2001-06-12 | 2002-12-19 | Glaxosmithkline Biologicals S.A. | Nouveaux composes |
GB0117762D0 (en) * | 2001-07-20 | 2001-09-12 | Glaxosmithkline Biolog Sa | Novel compounds |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
MXPA04008890A (es) | 2002-03-15 | 2005-10-18 | Wyeth Corp | Mutantes de la proteina p4 de haemophilus influenzae no tipicable con actividad enzimatica reducida. |
CA2604363C (fr) | 2005-04-08 | 2015-06-16 | Wyeth | Composition conjuguee polysaccharide-proteine pneumococcique polyvalente |
US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
KR20070047455A (ko) * | 2005-11-02 | 2007-05-07 | 삼성에스디아이 주식회사 | 전자 방출 표시 디바이스 |
AU2007224034B2 (en) | 2006-03-07 | 2012-03-29 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
PT1915913E (pt) * | 2006-10-23 | 2016-02-16 | Nestec Sa | Modulação do sabor e do aroma de produtos lácteos por biotransformação |
AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
WO2010079739A1 (fr) * | 2009-01-07 | 2010-07-15 | 大塚製薬株式会社 | Procédé de dosage applicable à tous les types de virus de la grippe |
PT3246044T (pt) | 2010-08-23 | 2021-02-15 | Wyeth Llc | Formulações estáveis de antigénios de rlp2086 de neisseria meningitidis |
NZ607224A (en) | 2010-09-10 | 2014-11-28 | Wyeth Llc | Non-lipidated variants of neisseria meningitidis orf2086 antigens |
TW201302779A (zh) * | 2011-04-13 | 2013-01-16 | Glaxosmithkline Biolog Sa | 融合蛋白質及組合疫苗 |
NZ628449A (en) | 2012-03-09 | 2016-04-29 | Pfizer | Neisseria meningitidis compositions and methods thereof |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
US9802987B2 (en) | 2013-03-08 | 2017-10-31 | Pfizer Inc. | Immunogenic fusion polypeptides |
EP4098276A1 (fr) | 2013-09-08 | 2022-12-07 | Pfizer Inc. | Compositions utilisables contre neisseria meningitidis et procédés associés |
KR20170103009A (ko) | 2015-02-19 | 2017-09-12 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
CN118021947A (zh) | 2017-01-31 | 2024-05-14 | 辉瑞大药厂 | 脑膜炎奈瑟菌组合物及其使用方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4220717A (en) * | 1977-12-22 | 1980-09-02 | American Cyanamid Company | Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b. |
US4220722A (en) * | 1978-02-10 | 1980-09-02 | Syva Company | Method for conjugating to polyamino compounds employing haloacyl groups and compositions prepared thereby |
US4356170A (en) * | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
US4496538A (en) * | 1982-07-06 | 1985-01-29 | Connaught Laboratories, Inc. | Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine |
US4661347A (en) * | 1982-11-12 | 1987-04-28 | Scripps Clinic | Cytotoxic compositions |
US4762713A (en) * | 1983-07-05 | 1988-08-09 | The University Of Rochester | Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers |
NZ214503A (en) * | 1984-12-20 | 1990-02-26 | Merck & Co Inc | Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates |
US4873090A (en) * | 1985-03-27 | 1989-10-10 | Broncostat Pty. Limited | Non-adjuvenated vaccine |
US4707543A (en) * | 1985-09-17 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines |
JP2534529B2 (ja) * | 1986-07-24 | 1996-09-18 | ブリティシュ・テレコミュニケ−ションズ・パブリック・リミテッド・カンパニ | 放射発生器 |
US5173294A (en) * | 1986-11-18 | 1992-12-22 | Research Foundation Of State University Of New York | Dna probe for the identification of haemophilus influenzae |
AU623353B2 (en) * | 1987-12-10 | 1992-05-14 | Board Of Regents, The University Of Texas System | Methods and compositions for the production of haemophilus influenzae type b major outer membrane protein antigens |
-
1990
- 1990-03-09 EP EP90905112A patent/EP0462210B1/fr not_active Expired - Lifetime
- 1990-03-09 AU AU53326/90A patent/AU648251B2/en not_active Expired
- 1990-03-09 US US07/491,466 patent/US5601831A/en not_active Expired - Lifetime
- 1990-03-09 DE DE69033600T patent/DE69033600T2/de not_active Expired - Lifetime
- 1990-03-09 CA CA002047681A patent/CA2047681C/fr not_active Expired - Lifetime
- 1990-03-09 DE DE69012318T patent/DE69012318T2/de not_active Expired - Lifetime
- 1990-03-09 KR KR1019910701102A patent/KR100188323B1/ko not_active IP Right Cessation
- 1990-03-09 ES ES90905112T patent/ES2063965T3/es not_active Expired - Lifetime
- 1990-03-09 DK DK94100492T patent/DK0606921T3/da active
- 1990-03-09 ES ES94100492T patent/ES2150450T3/es not_active Expired - Lifetime
- 1990-03-09 EP EP94100492A patent/EP0606921B1/fr not_active Expired - Lifetime
- 1990-03-09 AT AT90905112T patent/ATE110965T1/de not_active IP Right Cessation
- 1990-03-09 AT AT94100492T patent/ATE195076T1/de not_active IP Right Cessation
- 1990-03-09 JP JP2505084A patent/JP2955014B2/ja not_active Expired - Lifetime
- 1990-03-09 DK DK90905112.0T patent/DK0462210T3/da active
- 1990-03-09 WO PCT/US1990/001317 patent/WO1990010458A1/fr active IP Right Grant
-
1991
- 1991-09-06 NO NO91913518A patent/NO913518L/no unknown
- 1991-09-09 FI FI914241A patent/FI914241A0/fi not_active Application Discontinuation
-
1995
- 1995-05-23 US US08/447,653 patent/US5780601A/en not_active Expired - Lifetime
- 1995-05-23 US US08/448,097 patent/US6420134B1/en not_active Expired - Fee Related
- 1995-05-23 US US08/449,406 patent/US5955580A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0606921B1 (fr) | 2000-08-02 |
JPH07508972A (ja) | 1995-10-05 |
DK0462210T3 (da) | 1994-10-10 |
ATE110965T1 (de) | 1994-09-15 |
DE69033600D1 (de) | 2000-09-07 |
ATE195076T1 (de) | 2000-08-15 |
AU5332690A (en) | 1990-10-09 |
ES2063965T3 (es) | 1995-01-16 |
EP0462210A1 (fr) | 1991-12-27 |
DE69012318T2 (de) | 1995-03-09 |
EP0606921A1 (fr) | 1994-07-20 |
DE69033600T2 (de) | 2001-04-05 |
KR100188323B1 (ko) | 1999-06-01 |
JP2955014B2 (ja) | 1999-10-04 |
AU648251B2 (en) | 1994-04-21 |
FI914241A0 (fi) | 1991-09-09 |
US5955580A (en) | 1999-09-21 |
DE69012318D1 (de) | 1994-10-13 |
NO913518L (no) | 1991-10-29 |
CA2047681C (fr) | 2000-02-01 |
US5780601A (en) | 1998-07-14 |
EP0462210B1 (fr) | 1994-09-07 |
WO1990010458A1 (fr) | 1990-09-20 |
ES2150450T3 (es) | 2000-12-01 |
NO913518D0 (no) | 1991-09-06 |
US6420134B1 (en) | 2002-07-16 |
US5601831A (en) | 1997-02-11 |
CA2047681A1 (fr) | 1990-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0606921T3 (da) | Fremgangsmåde til isolering af Haemophilus influenzae protein E | |
NO871333D0 (no) | Kinolin-3-karboksylsyrederivater, fremgangsmaate til fremstilling og anvendelse derav. | |
IT8619684A0 (it) | Preparato di acido ialuronico chimicamente modificato e metodo per recuperarlo da tessuti animali. | |
ATE126223T1 (de) | Verfahren zur herstellung von ascorbinsäure. | |
DE3762604D1 (de) | Verfahren zur herstellung von waessrigen loesungen von freiem hydroxylamin. | |
DE69403210T2 (de) | Verfahren zur herstellung von n-acetylneuraminsäure | |
NO873198L (no) | Fremgangsmaate for gjenvinning av metaller. | |
DK498183D0 (da) | Fremgangsmade til fjernelse af oligomere og langsom monomer fra leukocyt-interferon (ifn-alfa)-praeparater | |
DE3761601D1 (de) | Verfahren zur aufarbeitung von kleinbatterien. | |
AU7881481A (en) | Recovery of l-phenylalanine and l-aspartic acid | |
DE3769425D1 (de) | Verfahren zur herstellung eines abgasfuehlers. | |
AU586352B2 (en) | Process for concentration of an aqueous solution of amino acid | |
DE3581541D1 (de) | Verfahren zur herstellung von zyklischen urea-derivaten. | |
JPS53127808A (en) | Preparation of human albumin | |
DE3688201D1 (de) | Verfahren zur herstellung von waessrigen loesungen von polysacchariden. | |
DE3763312D1 (de) | Verfahren zur herstellung von hexaalkyldisilan. | |
DE3676899D1 (de) | Verfahren zur herstellung von n-methyl-lysergol. | |
JPS5559146A (en) | Isolation of phenylalanine | |
ATA257786A (de) | Verfahren zur herstellung galenischer zubereitungen | |
Kamoi et al. | Method of permanent fixation by an alveolar bar | |
JPS5433877A (en) | Method of filtration of solution containing protein or amino acid | |
AU583464C (en) | Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues. | |
RO93222A2 (fr) | Procede pour l'obtention de l'acide 1,4-dihydroxy-2-naphtoique | |
NZ236206A (en) | Preparation of 2'-methyl-4'-methylenespiro(androstadiene-17,5'(4'h)-oxazol)-3-one derivatives from pregn-5-en-20-ylideneacetamide derivatives by treatment with vilsmeier reagent or acid | |
IE863232L (en) | Method for the recovery of proteins |